土耳其的囊性纤维化新生儿查计划:假阴性测试的经验和优化需求
Fevziye Çoksüer1, Gökçen Kartal Öztürk1, Handan Duman Şenol2
1Department of Pediatric Pulmonology, Ege University Faculty of Medicine, İzmir, Türkiye
Balkan medical journal
|November 22, 2024
概括
土耳其的新生儿查囊性纤维化 (CF) 使用IRT-1/IRT-2具有低灵敏度和高错误阳性率. 调整截止值或策略至关重要,以减少错过的诊断,并提高CF新生儿查的有效性.
科学领域:
- 新生儿查 新生儿查
- 儿科肺病学 儿科肺病学
- 遗传疾病的诊断 遗传疾病的诊断
背景情况:
- 2015年1月在土耳其启动的全国性囊性纤维化新生儿血点查 (CF-NBS) 计划,使用连续免疫反应性试素 (IRT-1/IRT-2) 测试.
- 该计划旨在通过血点分析检测新生儿的囊性纤维化 (CF).
研究的目的:
- 评估土耳其国家CF查计划的有效性.
- 为了确定IRT-1/IRT-2的最佳切断值.
- 确定在CF新生儿查中减少晚诊断的错误阴性患者 (FNP) 的策略.
主要方法:
- 进行了一项回顾性队列研究.
- 新生儿的血斑在出生后48-72小时内被收集,用于IRT-1/IRT-2测试,切断值分别为90μg/l和70μg/l.
- 有高IRT水平的婴儿接受了汗水测试 (ST);诊断包括CF,CRMS/CFSPID和假阳性NBS,以及临床诊断的FNP.
主要成果:
- 在227名NBS阳性婴儿中,53名 (23.34%) 患有CF,11名 (4.84%) 是CRMS/CFSPID,163名 (71.8%) 是假阳性.
- 66名婴儿被诊断为CF;80.3%是NBS阳性,而19.7%是临床诊断的FNP.
- 该IRT/IRT协议的灵敏度为80.3%,正预测值为23.3%.
结论:
- 目前在土耳其用于CF新生儿查的IRT/IRT协议具有低灵敏度和PPV,错误阳性和FNP的高率,使其不切实际.
- 在CF新生儿查中,假阴性结果导致显著的诊断延迟,并破坏了查目标.
- 修订IRT-1/IRT-2截止值或实施替代策略对于最大限度地减少遗漏的CF诊断至关重要.
相关概念视频
Cystic Fibrosis: Management
142
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
142
Cystic Fibrosis: Pathogenesis
192
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
192


